Agora Inc (API) is a good buy right now for a beginner-focused, long-term investor with $50,000-$100,000 to deploy. The stock has a constructive technical setup, improving fundamentals, and a mildly supportive options sentiment. Given the current price near support and the recent Q1 revenue growth, this looks like a reasonable long-term entry rather than a speculative trade.
API shows a bullish short-to-medium term technical trend. MACD histogram is positive and expanding, which supports upward momentum. The moving average structure is bullish with SMA_5 > SMA_20 > SMA_200, indicating the trend is aligned upward across multiple timeframes. RSI_6 at 73.504 suggests the stock is somewhat extended near term, but not enough to invalidate the trend. Price at 4.255 is near resistance/pivot around 4.267, with support at 3.931. Overall, the chart favors continuation if it can hold above the pivot zone.

["Q1 2025 revenue rose 13.4% year over year to $37.75 million.", "GAAP EPS improved to $0.01, showing gradual profitability recovery.", "BofA kept a Buy rating on the stock despite lowering the target, which still implies upside from current levels.", "Bullish technical structure with MACD expansion and stacked moving averages.", "Strong options sentiment with a very low put-call ratio."]
["The latest EPS was only $0.01, so profitability is still thin.", "BofA lowered its price target from $7.10 to $6.60, reflecting a more conservative valuation view.", "RSI is relatively elevated, so near-term upside could be less smooth.", "No meaningful hedge fund or insider accumulation trend is visible.", "No recent congress trading data or notable politician/influencer activity was reported."]
In the latest quarter, Q1 2025, Agora delivered revenue of $37.75 million, up 13.4% year over year, which shows clear top-line growth. GAAP EPS was $0.01, indicating a small profit and a modest improvement in profitability. For a long-term investor, the key takeaway is that the company is moving in the right direction operationally, though earnings quality remains early-stage and not yet robust.
Recent analyst activity is still favorable overall. On 2026-05-27, BofA analyst Daley Li lowered the price target to $6.60 from $7.10 but maintained a Buy rating, citing valuation rollover after a Q1 beat and possible Q2 growth acceleration. This is a mildly positive Wall Street view: pros see improving growth and potential acceleration, while the main con is that valuation upside has been trimmed and earnings are still thin.